158 related articles for article (PubMed ID: 29147011)
1. Lower serum extracellular superoxide dismutase levels are associated with polyneuropathy in recent-onset diabetes.
Strom A; Kaul K; Brüggemann J; Ziegler I; Rokitta I; Püttgen S; Szendroedi J; Müssig K; Roden M; Ziegler D
Exp Mol Med; 2017 Nov; 49(11):e394. PubMed ID: 29147011
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
Schamarek I; Herder C; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
Eur J Endocrinol; 2016 Apr; 174(4):433-43. PubMed ID: 26733478
[TBL] [Abstract][Full Text] [Related]
5. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
Ziegler D; Strom A; Bönhof GJ; Kannenberg JM; Heier M; Rathmann W; Peters A; Meisinger C; Roden M; Thorand B; Herder C
BMJ Open Diabetes Res Care; 2019; 7(1):e000752. PubMed ID: 31803481
[TBL] [Abstract][Full Text] [Related]
6. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
Mohammedi K; Bellili-Muñoz N; Marklund SL; Driss F; Le Nagard H; Patente TA; Fumeron F; Roussel R; Hadjadj S; Marre M; Velho G
Cardiovasc Diabetol; 2015 Jan; 14():845. PubMed ID: 25855220
[TBL] [Abstract][Full Text] [Related]
7. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
8. Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.
Ziegler D; Bönhof GJ; Strom A; Straßburger K; Karusheva Y; Szendroedi J; Roden M
Brain; 2021 Nov; 144(10):3251-3263. PubMed ID: 34499110
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes.
Okdahl T; Brock C; Fløyel T; Wegeberg AL; Jakobsen PE; Ejskjaer N; Pociot F; Brock B; Størling J
Clin Endocrinol (Oxf); 2020 Oct; 93(4):419-428. PubMed ID: 32497255
[TBL] [Abstract][Full Text] [Related]
10. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.
Kuo CW; Chen HL; Tu MY; Chen CM
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F32-F41. PubMed ID: 30303710
[TBL] [Abstract][Full Text] [Related]
11. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study.
Herder C; Thorand B; Strom A; Rathmann W; Heier M; Koenig W; Morrison H; Ziegler D; Roden M; Peters A; Bönhof GJ; Maalmi H
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3807. PubMed ID: 38872492
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy.
Bönhof GJ; Strom A; Püttgen S; Ringel B; Brüggemann J; Bódis K; Müssig K; Szendroedi J; Roden M; Ziegler D
Diabetologia; 2017 Dec; 60(12):2495-2503. PubMed ID: 28914336
[TBL] [Abstract][Full Text] [Related]
13. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
Weng YC; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Chen CM; Hwang JS; Kuo HC
J Diabetes Res; 2020; 2020():6356459. PubMed ID: 32695829
[TBL] [Abstract][Full Text] [Related]
14. High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
Aso Y; Iijima T; Jojima T; Saito M; Tanuma D; Kase M; Sakurai S; Tomaru T; Usui I
Postgrad Med; 2024 Apr; 136(3):318-324. PubMed ID: 38660919
[TBL] [Abstract][Full Text] [Related]
15. Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus.
Chang KH; Chen CM; Lin CN; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Weng YC; Hwang JS; Kuo HC
J Peripher Nerv Syst; 2023 Dec; 28(4):651-663. PubMed ID: 37831393
[TBL] [Abstract][Full Text] [Related]
16. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
[TBL] [Abstract][Full Text] [Related]
18. Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.
Tsilingiris D; Schimpfle L; von Rauchhaupt E; Sulaj A; Seebauer L; Herzig S; Szendroedi J; Kopf S; Κender Ζ
Diabetes; 2024 Jan; 73(1):135-146. PubMed ID: 37862374
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy.
Kasznicki J; Kosmalski M; Sliwinska A; Mrowicka M; Stanczyk M; Majsterek I; Drzewoski J
Mol Biol Rep; 2012 Sep; 39(9):8669-78. PubMed ID: 22718504
[TBL] [Abstract][Full Text] [Related]
20. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
